Key statistics
On Friday, HUTCHMED (China) Ltd (H7T2:DEU) closed at 2.42, 19.80% above the 52 week low of 2.02 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.46 |
---|---|
High | 2.62 |
Low | 2.42 |
Bid | 2.44 |
Offer | 2.74 |
Previous close | 2.46 |
Average volume | 0.00 |
---|---|
Shares outstanding | 871.61m |
Free float | 501.29m |
P/E (TTM) | 69.99 |
Market cap | 20.70bn HKD |
EPS (TTM) | 0.3393 HKD |
Data delayed at least 15 minutes, as of Jun 27 2025.
More ▼
- Blocklisting Six Monthly Return
- China Approval based on Phase III SACHI Trial
- Total Voting Rights
- HUTCHMED Announces China Approval for ORPATHYS® in Combination with TAGRISSO® for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line EGFR Inhibitor Therapy
- Grant of Share Options and Awards under LTIP
- HUTCHMED and Innovent Announce NDA Acceptance
- HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma
- HUTCHMED Highlights SACHI Phase III Data at ASCO
- HUTCHMED Highlights SACHI Phase III Study Data Presented at the 2025 ASCO Annual Meeting
- Total Voting Rights
More ▼